These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30151081)

  • 1. Synthesis and antitumoral activity of novel analogues monastrol-fatty acids against glioma cells.
    De Oliveira FS; De Oliveira PM; Farias LM; Brinkerhoff RC; Sobrinho RCMA; Treptow TM; Montes D'Oca CR; Marinho MAG; Hort MA; Horn AP; Russowsky D; Montes D'Oca MG
    Medchemcomm; 2018 Aug; 9(8):1282-1288. PubMed ID: 30151081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel fatty acid 3,4-dihydropyrimidin-2-(1
    Rios EAM; Dea CM; Dos Santos ERFB; D'Oca MGM; Rampon DS; Nachtigall FM; Santos LS; Guzman L; Moore-Carrasco R; Rebolledo-Mira D; D'Oca CRM
    RSC Adv; 2024 Jul; 14(32):22981-22987. PubMed ID: 39040706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel hybrid DHPM-fatty acids: synthesis and activity against glioma cell growth in vitro.
    Treptow TG; Figueiró F; Jandrey EH; Battastini AM; Salbego CG; Hoppe JB; Taborda PS; Rosa SB; Piovesan LA; Montes D'Oca Cda R; Russowsky D; Montes D'Oca MG
    Eur J Med Chem; 2015 May; 95():552-62. PubMed ID: 25863023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and differential antiproliferative activity of Biginelli compounds against cancer cell lines: Monastrol, oxo-monastrol and oxygenated analogues.
    Russowsky D; Canto RF; Sanches SA; D'Oca MG; de Fátima A; Pilli RA; Kohn LK; Antônio MA; de Carvalho JE
    Bioorg Chem; 2006 Aug; 34(4):173-82. PubMed ID: 16765411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic monastrol derivatives as adjective inhibitors of drug-resistant Eg5: a molecular dynamics perspective.
    Shahabipour S; Shamkhali AN; Razzaghi-Asl N
    J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38450658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors.
    El-Hamamsy MH; Sharafeldin NA; El-Moselhy TF; Tawfik HO
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000060. PubMed ID: 32452567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monastrol mimic Biginelli dihydropyrimidinone derivatives: synthesis, cytotoxicity screening against HepG2 and HeLa cell lines and molecular modeling study.
    Soumyanarayanan U; Bhat VG; Kar SS; Mathew JA
    Org Med Chem Lett; 2012 Jun; 2(1):23. PubMed ID: 22691177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New chemical tools for investigating human mitotic kinesin Eg5.
    Klein E; DeBonis S; Thiede B; Skoufias DA; Kozielski F; Lebeau L
    Bioorg Med Chem; 2007 Oct; 15(19):6474-88. PubMed ID: 17587586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
    Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
    J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
    Peters T; Lindenmaier H; Haefeli WE; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):291-9. PubMed ID: 16365780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty-monastrol derivatives and its cytotoxic effect against melanoma cell growth.
    de Moraes MM; Treptow TGM; Teixeira WKO; Piovesan LA; D'Oca MGM; Votto APS
    Bioorg Chem; 2017 Jun; 72():148-155. PubMed ID: 28460356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and molecular modeling of six novel monastrol analogues: evaluation of cytotoxicity and kinesin inhibitory activity against HeLa cell line.
    Abnous K; Barati B; Mehri S; Masboghi Farimani MR; Alibolandi M; Mohammadpour F; Ghandadi M; Hadizadeh F
    Daru; 2013 Dec; 21(1):70. PubMed ID: 24355209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monastrol inhibition of the mitotic kinesin Eg5.
    Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
    J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-1 arylation of monastrol on kinesin Eg5 inhibition in glioma cell lines.
    Gonçalves IL; Rockenbach L; das Neves GM; Göethel G; Nascimento F; Porto Kagami L; Figueiró F; Oliveira de Azambuja G; de Fraga Dias A; Amaro A; de Souza LM; da Rocha Pitta I; Avila DS; Kawano DF; Garcia SC; Battastini AMO; Eifler-Lima VL
    Medchemcomm; 2018 Jun; 9(6):995-1010. PubMed ID: 30108989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient exposure to the Eg5 kinesin inhibitor monastrol leads to syntelic orientation of chromosomes and aneuploidy in mouse oocytes.
    Mailhes JB; Mastromatteo C; Fuseler JW
    Mutat Res; 2004 Apr; 559(1-2):153-67. PubMed ID: 15066583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule and mutational analysis of allosteric Eg5 inhibition by monastrol.
    Maliga Z; Mitchison TJ
    BMC Chem Biol; 2006 Feb; 6():2. PubMed ID: 16504166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparity in allosteric interactions of monastrol with Eg5 in the presence of ADP and ATP: a difference FT-IR investigation.
    Wojcik EJ; Dalrymple NA; Alford SR; Walker RA; Kim S
    Biochemistry; 2004 Aug; 43(31):9939-49. PubMed ID: 15287721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.